Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients

Sterna Biologicals GmbH & Co. KG · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
ulcerative-colitis
colitis, ulcerative, antisense oligonucleotide, colitis ulcerosa, ulcerative colitis, phase ii, transcription factor gata-3, intrarectal application, proof-of-concept, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 873339
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.